Classification of tea category using a portable electronic nose based on an odor imaging sensor array

被引:100
作者
Chen, Quansheng [1 ]
Liu, Aiping [1 ]
Zhao, Jiewen [1 ]
Ouyang, Qin [1 ]
机构
[1] Jiangsu Univ, Sch Food & Biol Engn, Zhenjiang 212013, Peoples R China
关键词
Tea; Classification; Electronic nose; Odor imaging sensor array; Multivariate calibration; HUMAN PLASMA; LIQUID-CHROMATOGRAPHY; LC-METHOD; ZOLMITRIPTAN; IMPURITIES;
D O I
10.1016/j.jpba.2013.05.046
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A developed portable electronic nose (E-nose) based on an odor imaging sensor array was successfully used for classification of three different fermentation degrees of tea (i.e., green tea, black tea, and Oolong tea). The odor imaging sensor array was fabricated by printing nine dyes, including porphyrin and metall-oporphyrins, on the hydrophobic porous membrane. A color change profile for each sample was obtained by differentiating the image of sensor array before and after exposure to tea's volatile organic compounds (VOCs). Multivariate analysis was used for the classification of tea categories, and linear discriminant analysis (LDA) achieved 100% classification rate by leave-one-out cross-validation (LOOCV). This study demonstrates that the E-nose based on odor imaging sensor array has a high potential in the classification of tea category according to different fermentation degrees. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:77 / 89
页数:13
相关论文
共 26 条
[1]  
[Anonymous], 2008, INT C HARM TECHN REQ
[2]  
[Anonymous], 1999, IARC MON PROGR EV CA, V71, P1059
[3]   CHEMICAL-STRUCTURE, SALMONELLA MUTAGENICITY AND EXTENT OF CARCINOGENICITY AS INDICATORS OF GENOTOXIC CARCINOGENESIS AMONG 222 CHEMICALS TESTED IN RODENTS BY THE UNITED-STATES NCI/NTP [J].
ASHBY, J ;
TENNANT, RW .
MUTATION RESEARCH, 1988, 204 (01) :17-115
[4]   High-performance liquid chromatographic analysis of zolmitriptan in human plasma using fluorescence detection [J].
Chen, J ;
Jiang, XG ;
Jiang, WM ;
Mei, N ;
Gao, XL ;
Zhang, QZ .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2004, 35 (03) :639-645
[5]   Determination of zolmitriptan in human plasma by liquid chromatography-tandem mass spectrometry method: Application to a pharmacokinetic study [J].
Chen, XY ;
Liu, D ;
Luan, Y ;
Jin, FD ;
Zhong, DF .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2006, 832 (01) :30-35
[6]   Simultaneous measurement of zolmitriptan and its major metabolites N-desmethylzolmitriptan and zolmitriptan N-oxide in human plasma by high-performance liquid chromatography with coulometric detection [J].
Clement, EM ;
Franklin, M .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2002, 766 (02) :339-343
[7]   Identification, preparation and UHPLC determination of process-related impurity in zolmitriptan [J].
Dousa, Michal ;
Gibala, Petr ;
Radl, Stanislav ;
Klecan, Ondrej ;
Mandelova, Zuzana ;
Brichac, Jiri ;
Pekarek, Tomas .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2012, 58 :1-6
[8]   Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs) [J].
Elder, D. P. ;
Lipczynski, A. M. ;
Teasdale, A. .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2008, 48 (03) :497-507
[9]  
European Medicines Agency, 2007, EV MED HUM US GUID L
[10]  
He H., 2005, YAOWU FENXI ZAZHI, V25, P323